²úÆ·¹©Ó¦¼×°±µûßʶþÄÆÑÎ

  • ·¢²¼ÈÕÆÚ£º2024-05-07
  • ÓÐЧÆÚÏÞ£º30Ìì
ºþ±±ºãÂÌÔ´¿Æ¼¼ÓÐÏÞ¹«Ë¾ VIP
231-022-0
C20H20N8Na2O5
498.4029

ÏêϸÐÅÏ¢
  • ;N-[4-[[(2,4-¶þ°±»ù-6-µûऻù)¼×»ù]¼×°·»ù]±½¼×õ£»ù]-L-¹È°±Ëá¶þÄÆÑÎ;¼×°·µûÒ÷¶þÄÆ»ù;¼×°±µûßʶþÄÆ;
  • Methotrexate disodium salt
  • ;disodium N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamate;disodium 2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)amino]pentanedioate;Methotrexate disodium;
  • InChI=1/C20H22N8O5.2Na/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);;/q;2*+1/p-2
  • CAS NO£º7413-34-5

ÃâÔðÉùÃ÷£ºÒÔÉÏËùչʾµÄÐÅÏ¢ÓÉÆóÒµ×ÔÐÐÌṩ£¬ÄÚÈݵÄÕæʵÐÔ¡¢×¼È·ÐԺͺϷ¨ÐÔÓÉ·¢²¼ÆóÒµ¸ºÔ𣬻¯¹¤Íø¶Ô´Ë²»³Ðµ£Èκα£Ö¤ÔðÈΡ£ÎÒÃÇÔ­ÔòÉϽ¨ÒéÄúÑ¡Ôñ»¯¹¤Íø¸ß¼¶»áÔ±»òVIP»áÔ±¡£